local_hospital

DAaCRO GmbH & Co. KG

Address
Max-Planck-Strasse 22, Kuerenz, 54296 Trier, Germany

DAaCRO GmbH & Co. KG - Sleep Disorders Research Center

DAaCRO GmbH & Co. KG is a specialized clinical research organization focusing on sleep medicine and natural pharmaceutical interventions. The center conducts rigorous clinical trials to evaluate the efficacy and safety of innovative therapeutic approaches for sleep-related disorders.

  • Insomnia treatment research with novel pharmaceutical formulations
  • Natural product-based therapies including Escholzia (California poppy) preparations
  • Sleep quality assessment and patient-reported outcome measures

The center employs comprehensive study designs combining randomized, placebo-controlled, double-blind phases with prospective follow-up periods to thoroughly evaluate both short-term efficacy and long-term safety profiles. Their expertise extends to conducting biphasic clinical trials that assess treatments for ICD-10 F51.0 insomnia diagnosis, with particular emphasis on perceived sleep quality improvements and establishing robust safety data for regulatory approval of new sleep medications.

Site Overview

assignment
1
connected trial
corporate_fare
1
sponsor
science
1
IMP

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
1
Total trials linked
Low Activity
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
1
Sponsors (total)
1
Active sponsors
1

Sponsor Network

Top 1 by active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 2 161 other sites in Germany

description
Trial volume
1
Outperforms 2% of sites
public
Therapeutic diversity
1areas
Outperforms 2% of sites
groups
Sponsor diversity
1sponsors
Outperforms 2% of sites

Therapeutic Area Benchmark — Germany

Select a therapeutic area to compare against other sites in Germany.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Germany

Market Share

Country: Germany

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in DAaCRO GmbH & Co. KG

Trial Sponsor Phase Status Start Date End Date
Evaluation of AV-EC2023 Efficacy and Safety in Insomnia: A Randomized, Placebo-Controlled, Double-Blind, Biphasic Clinical Trial in AdultsA.Vogel AGPhase IIINot Yet Recruiting

IMP list

IMP Trials Status First start Last start
Av-Ec20231Unknown

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.